SCHEMBL27306270

SCHEMBL27306270

Cn1cc(C(=O)CCl)cc1C(=O)NCc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP4 Q13107 1/20 0.72
USP7 Q93009 1/20 0.72
LMNA P02545 3/20 0.51
PKM P14618 2/20 0.49
BRD4 O60885 1/20 0.49
RAB9A P51151 4/20 0.48
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
PHGDH O43175 1/20 0.46
KLKB1 P03952 1/20 0.46
HDAC2 Q92769 2/20 0.45
HDAC8 Q9BY41 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27312350 0.77 USP4 (0.51) USP4USP7LMNAPKMALDH1A1
SCHEMBL2736608 0.73 ALDH1A1 (0.59) LMNABRD4RAB9AALDH1A1MEN1
SCHEMBL13272883 0.73 NPC1 (0.73) BRD4RAB9AKMT2AHDAC2HDAC8
SCHEMBL8483573 0.72 ERCC1 (0.59) USP4USP7POLBHDAC2HDAC8
SCHEMBL9013681 0.72 PKM (0.56) USP4USP7LMNAPKMALDH1A1
SCHEMBL16403976 0.72 LMNA (0.48) LMNARAB9AALDH1A1MEN1KMT2A
SCHEMBL1149552 0.72 HDAC3 (0.56) LMNARAB9AALDH1A1MEN1KMT2A
SCHEMBL29190969 0.71 USP4 (0.61) USP4USP7KLKB1HDAC2HDAC8
SCHEMBL19753892 0.71 LMNA (0.46) LMNABRD4RAB9AALDH1A1MEN1
SCHEMBL6179001 0.70 TDP1 (0.65) LMNAPKMRAB9AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024006956-A9 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-04-11 WO disclosed
WO-2024006956-A2 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-01-04 WO disclosed